Three teenage college students drown in River Netravati while celebrating birthday

Bantwal, Feb 2: A 45-year-old man was found murdered in a parked Innova car at Shantinagar near Nagri in Sajipa Munnur in Bantwal taluk today. 

The deceased has been identified as Tasleem, a native of Kerala who was wanted in a few criminal cases. He was, according to reports, a member of Kerala's notorious Ziya. 

Tasleem was an accused in Kalia Rafiq murder in Ullal (2017). He was arrested last year in connection with a jewellery store robbery case registered in Mangaluru North police station and was sent to Kalaburagi prison. He was later released on bail. 

Police are of the suspicion that a rival gang might have kidnapped him, tried to strangle him and then stabbed him in the stomach, before fleeing the spot.

The car had been parked at the spot since morning. The locals who grew suspicious at this informed the police. Circle inspector T D Nagaraj and other officers conducted spot investigation. 

Bengaluru, May 24: Karnataka has conducted 2.03 lakh tests across the 57 Indian Council of Medical Research (ICMR) COVID-19 testing labs till Sunday morning, said the state Minister of Medical Education Dr K Sudhakar.

He informed that the state has doubled the number of tests in just 16 days after clocking 1 lakh tests on May 8.

"After clocking 1 lakh tests on May 8, we have doubled the number of tests in just 16 days. As on this morning, we conducted 2.03 lakh tests across our 57 ICMR COVID-19 testing labs. I congratulate doctors and lab technicians on this achievement," Sudhakar tweeted.

As many as 1,743 people have been detected positive for coronavirus in the state, of which 597 have been cured and discharged and 41 have succumbed to the infection, as per the Union Health Ministry. 

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.